Moderna has paid $400 million to the government for a chemical technique key to its vaccine.

Health & Wellness:

• As part of the agreement with the NIH, Moderna will pay the agency $400 million in royalties for the use of its patented technology.

• The payout is a result of the NIH's investment in the development of the vaccine, as well as its contribution to the underlying technology used in the vaccine.

• The agreement also includes provisions for future collaboration …